Novel Clinical Research (India) Private Limited - Company Profile

It is a research & development foreign private limited company based in Bangalore, Karnataka, India, established in 2012.
2012 Bangalore, Karnataka, India Struck Off
Last Updated:
Access Report
About Novel Clinical Research (India) Private Limited

Novel Clinical Research (India) Private Limited, a struck off foreign private limited company, was established on 06 December 2012 in Bangalore, Karnataka, India. Engaging in research & development within the research & development sector, it holds CIN: U73100KA2012FTC067065. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Sunil Makharia (Director), Nilesh Deshbandhu Gupta (Director). Past directors included Sunil Makharia, Nilesh Deshbandhu Gupta, Veerappan Sellappan Subramanian. Its latest AGM occurred on 31 July 2017, with the balance sheet filed on 31 March 2017. It is based at 854/1, Pp Industrial Area, Mysore Road, Deepanjali Nagar, Bangalore, Karnataka, 560026.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100KA2012FTC067065

  • Registration Number

    067065

  • Incorporation Date

    06 December 2012

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 2 Months
  • Last Filing with ROC 31 Mar 2017
Company report

Novel Clinical Research (India) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Novel Clinical Research (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Novel Clinical Research (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Sunil Makharia Director 17 Oct 2016 Current
Nilesh Deshbandhu Gupta Director 17 Oct 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 31 Jul 2017 Past
Pramod Abcsdd Additional Director 31 Jul 2017 Past
Pramod Abcsdd Nominee Director 01 Dec 2016 Past
Pramod Abcsdd Director 01 Dec 2016 Past
Pramod Abcsdd Director 01 Dec 2016 Past
Pramod Abcsdd Director 01 Dec 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Novel Clinical Research (India).

Enhance accessibility to Novel Clinical Research (India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Novel Clinical Research (India) revenue growth over time
Novel Clinical Research (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Novel Clinical Research (India)?

In 2017, Novel Clinical Research (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Novel Clinical Research (India)?

Unlock and access historical data on people associated with Novel Clinical Research (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Novel Clinical Research (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novel Clinical Research (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Novel Clinical Research (India)
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Novel Clinical Research (India) Private Limited last Annual general meeting of members was held on 31 Jul 2017 as per latest MCA records. was documented.

  • Balance Sheet

    Novel Clinical Research (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Bangalore. was recorded as a recent event.

  • Director Appointment

    The activity Sunil Makharia was appointed as a Director was appointed as a Director on 17 Oct 2016 & has been associated with this company since 9 years 4 months . was completed.

  • Director Appointment

    The activity Nilesh Deshbandhu Gupta was appointed as a Director was appointed as a Director on 17 Oct 2016 & has been associated with this company since 9 years 4 months . was completed.

  • Company Incorporation

    Progress on Novel Clinical Research (India) Private Limited was registered on 06 Dec 2012 with Roc Bangalore & aged 13 years 2 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Novel Clinical Research (India) Private Limited?

The CIN of Novel Clinical Research (India) Private Limited is U73100KA2012FTC067065.

Where is Novel Clinical Research (India) Private Limited headquartered?

Novel Clinical Research (India) Private Limited is headquartered at 854/1, Pp Industrial Area, Mysore Road, Deepanjali Nagar, Bangalore, Karnataka, 560026.

When was Novel Clinical Research (India) Private Limited incorporated?

Novel Clinical Research (India) Private Limited was incorporated on 06 December 2012.

Who are the current directors of Novel Clinical Research (India) Private Limited?

The current directors of Novel Clinical Research (India) Private Limited are

What is the primary industry of Novel Clinical Research (India) Private Limited?

The primary industry of Novel Clinical Research (India) Private Limited is Research & Development.

Is Novel Clinical Research (India) Private Limited a listed company?

Novel Clinical Research (India) Private Limited is unlisted.

What is the capital structure of Novel Clinical Research (India) Private Limited?

The authorized capital of Novel Clinical Research (India) Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available